Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05393791
Title Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC (ANZadapt)
Acronym ANZadapt
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Leiden University Medical Center
Age Groups: senior | adult
Covered Countries NLD | AUS

No variant requirements are available.